Lars K. Markvardsen
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Predictors of relapses in patients with chronic inflammatory demyelinating polyneuropathy receiving subcutaneous immunoglobulin therapy - a post-hoc analysis.
Journal: Journal of neuromuscular diseases
Published: April 29, 2026
Association Between MScanFit Motor Unit Number Estimation and Clinical Function and Response to Immunoglobulin Therapy in Chronic Inflammatory Demyelinating Polyneuropathy.
Journal: Journal of the peripheral nervous system : JPNS
Published: August 19, 2024
Standardized Tapering off Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy.
Journal: Journal of neuromuscular diseases
Published: July 02, 2023
Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
Journal: Journal of the peripheral nervous system : JPNS
Published: April 03, 2023
Critical illness myopathy as a consequence of Covid-19 infection.
Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Published: June 03, 2020
Quality of life in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin.
Journal: Acta neurologica Scandinavica
Published: April 03, 2020
Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort.
Journal: Pediatric neurology
Published: November 21, 2019
Chronic inflammatory demyelinating polyneuropathy
Journal: Ugeskrift for laeger
Published: August 01, 2019
Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats.
Journal: Journal of vascular research
Published: April 25, 2019
Last Updated: 09/26/2026